AzTrials
AzTrials

Musculoskeletal InjuryNCT05719922

The ADAPTation to Therapeutic Resistance Training (ADAPT) Study

A study testing Resistance Training in people with Musculoskeletal Injury and Muscle Weakness, run by Defence Medical Rehabilitation Centre, UK at 6 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In 2018, the Academic Department of Military Rehabilitation (ADMR) published a pilot randomised controlled trial (RCT), demonstrating the feasibility and acceptability of integrating twice-daily blood flow restriction (BFR) training into a busy residential care setting. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Musculoskeletal Injury, Muscle Weakness
What is being tested?
Resistance Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
6 sitesUnited Kingdom
Study dates
1 Dec 2022to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • mechanical knee pain for at least three months
  • present with clinical signs and symptoms of knee pain arising from the tibiofemoral or patellofemoral joint diagnosed by sport and exercise medicine physician and/or physiotherapist
  • have reduced occupational employability medical grade secondary to their knee pain
  • report progression of resistance training load within the patient's rehabilitation programme is limited by knee pain
  • aged between 18 and 55 years
  • available to attend for the entire duration of the RRU course and a review appointment 3-months following course.

Who cannot join

  • diagnosed tibial, femoral or patella fracture and/or dislocation;
  • present with instability in the knee resulting from ligament deficiency
  • present with clinical signs and symptoms of patellar tendinopathy
  • have planned surgery over the study period
  • restricted knee range of movement; clinical signs and symptoms of non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour) or referred pain from non-local pain source
  • present with any physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the rehabilitation programme and/or assessment procedures
Show all 19Show fewer
  • Cortico-steroid or analgesic injection intervention within the previous 7-days or previous knee surgery within the last 12 months to the affected limb
  • Medical Exclusion Criteria:
  • History of cardiovascular disease including hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction.
  • History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis.
  • History of the following neurological disorders: Peripheral neuropathy, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, severe traumatic brain injury.
  • Varicose veins in the lower limb
  • Acute viral or bacterial upper or lower respiratory infection at screening
  • Known or suspected lower limb chronic exertional compartment syndrome (CECS)
  • Postsurgical swelling
  • Surgical insertion of metal components at the position of cuff inflation
  • History of any of the following conditions or disorders not previously listed: diabetes, active cancer
  • History of elevated risk of unexplained fainting or dizzy spells during physical activity/exercise that causes loss of balance
  • History of haemorrhagic stroke or exercise induced rhabdomyolysis

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United Kingdom6 sites, 6 recruiting
  • RRU Aldershot

    Aldershot

    Ollie Rosenstock

    Recruiting
  • RRU Colchester

    Colchester

    Rachel Spanner

    Recruiting
  • RRU Cranwell

    Cranwell

    Recruiting
  • RRU Edinburgh

    Edinburgh

    Gordon McKay

    Recruiting
  • RRU St Athan

    St Athan

    Recruiting
  • RRU Bulford

    Tidworth

    Alice Essam

    Recruiting

Other trials in United Kingdom

About this study

Official title: Low-load Blood Flow Restriction Exercise Versus Conventional Heavier Load Resistance Training Exercise in UK Military Personnel With Persistent Knee Pain: A Multi-centre Randomized Controlled Trial

In 2018, the Academic Department of Military Rehabilitation (ADMR) published a pilot randomised controlled trial (RCT), demonstrating the feasibility and acceptability of integrating twice-daily blood flow restriction (BFR) training into a busy residential care setting. Following its publication was a guidance note written by the Directorate of Defence Rehabilitation restricting the implementation of BFR training until more evidence can be provided to support its efficacy. This research trial is a fully-powered, multi-centre RCT investigating the efficacy and biological mechanism underpinning BFR therapy in UK military personnel with lower-limb musculoskeletal injury (specifically, persistent anterior knee pain) during residential rehabilitation. This study will aim to optimise both the rehabilitation outcome and improve the time-and cost-effectiveness of the service delivered across UK Defence Rehabilitation and beyond. Results will provide insight and knowledge to the clinical and scientific community to not only those embedded within Defence Rehabilitation, but also those working in civilian sector organisations and professional sport in the UK and abroad.

Keywords
Musculoskeletal rehabilitation, Blood flow restriction, Resistance training, knee pain, military
Medical subject headings
Muscle Weakness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance TrainingOther

    Comparing two different exercise-based treatment methodologies on the clinical outcomes of individuals with persistent knee pain.

Study groups in NCT05719922
Study groupRoleWhat they receive
Low-load blood flow restriction training (LL-BFR)ExperimentalTwice daily LL-BFR for 3 weeks
Receives: Other: Resistance Training
Heavier load resistance training (HL-RT)Active comparatorThree sessions per week for 3 weeks
Receives: Other: Resistance Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Lower Extremity Functional Scale (LEFS) over time

    LEFS is a 20-question patient-reported outcome measure (PROM) that measures functional status in patients with lower limb musculoskeletal injury. Questions on activity vary in physical demand from walking to running on uneven ground. The LEFS is a validated tool and has demonstrated good test-retest reliability and responsiveness in individuals with persistent knee pain.

    Measured: Baseline, week 3 and week 15

Secondary outcomes (29)
  1. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) over time

    Measured: Baseline, week 3 and week 15

  2. Change in Patient Specific Functional Scale over time

    Measured: Baseline, week 3 and week 15

  3. Change in Musculoskeletal Health Questionnaire (MSK-HQ) over time

    Measured: Baseline, week 3 and week 15

  4. Change in Tampa Scale of Kinesiophobia (TSK) over time

    Measured: Baseline, week 3 and week 15

  5. Health Anxiety Depression Scale (HADS)

    Measured: Baseline

  6. Change in International Physical Activity Questionnaire (IPAQ) over time

    Measured: Baseline, week 3 and week 15

  7. Change in Numeric Pain Rating Scale (NPRS) over time

    Measured: Baseline, week 3 and week 15

  8. Change in Sport Injury Rehabilitation Beliefs Survey (SIRBS) over time

    Measured: Baseline, week 3 and week 15

  9. Change in functional Activity Assessment (FAA) over time

    Measured: Baseline and week 15

  10. Change in five Repetition Maximum Leg Press over time

    Measured: Baseline, week 3 and week 15

  11. Change in isometric muscle strength of hip and knee using hand-held dynamometer over time

    Measured: Baseline, week 3 and week 15

  12. Change in single leg heel raises to fatigue over time

    Measured: Baseline, week 3 and week 15

  13. Change in qualitative assessment of single leg squat (QASLS) over time

    Measured: Baseline, week 3 and week 15

  14. Change in decline knee bend over time

    Measured: Baseline, week 3 and week 15

  15. Change in isometric midthigh pull over time

    Measured: Baseline, week 3 and week 15

  16. Change in counter-movement jump over time

    Measured: Baseline, week 3 and week 15

  17. Change in knee extension and flexion - maximal isometric voluntary contraction over time

    Measured: Baseline, week 3 and week 15

  18. Change in muscle volume and anatomical cross sectional area (CSA) using magnetic resonance imaging (MRI) over time

    Measured: Baseline, week 3 and week 15

  19. Change in pennation angle over time using ultrasonography

    Pennation angle measured in degrees

    Measured: Baseline, week 3 and week 15

  20. Change in fascicle length over time using ultrasonography

    fascicle length measured in mm

    Measured: Baseline, week 3 and week 15

  21. Change in single leg squat over time - kinetic and kinematic analysis

    3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg

    Measured: Baseline, week 3 and week 15

  22. Change in bilateral squat over time - kinetic and kinematic analysis

    3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg

    Measured: Baseline, week 3 and week 15

  23. Change in markers of muscle damage over time

    Using fasted blood samples. E.g., Creatine Kinase (units/L)

    Measured: Baseline, week 3 and week 15

  24. Change in markers of oxidative stress over time

    Using fasted blood samples. E.g., Protein carbonyl (units/L)

    Measured: Baseline, week 3 and week 15

  25. Change in markers of inflammation over time

    Using fasted blood samples. E.g., Interleukin-6 (pg/ml)

    Measured: Baseline, week 3 and week 15

  26. Change in markers of endothelial function over time

    Using fasted blood samples. E.g., Vascular endothelial growth factor (µg/L)

    Measured: Baseline, week 3 and week 15

  27. Change in daily monitoring of wellness score over time

    Subjective patient reported outcome measure of 'wellness' scored using a 5-point likert scale.

    Measured: Daily for the 3 weeks of rehabilitation

  28. Change in daily monitoring of session rate of perceived exertion (sRPE) over time

    Subjective patient reported outcome measure of exertion, scored 0 to 10 (0 = no exertion, 10= maximal exertion)

    Measured: Daily for the 3 weeks of rehabilitation

  29. Change in daily monitoring of pain over time

    Subjective patient reported outcome measure of pain measured using a 0 to 100mm visual analog scale (VAS). 0= no pain, 100 = worst pain

    Measured: Daily for the 3 weeks of rehabilitation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2023
  2. Study start1 Dec 2022
  3. Primary completion31 Aug 2024 (estimated)
  4. Study completion31 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05719922
Sponsor's protocol ID
DefenceMedRC
Status last verified
Jan 2023
First submitted
19 Jan 2023
Last updated
9 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymised participant data will be made available upon reasonable request to the chief investigator.

Publications

  • Cassidy RP, Lunt KM, Coppack RJ, Bennett AN, Bilzon JLJ, Mcguigan MP, Egginton N, Sellon E, Day J, Ladlow P. ADAPTations to low load blood flow restriction exercise versus conventional heavier load resistance exercise in UK military personnel with persistent knee pain: protocol for the ADAPT study, a multi-centre randomized controlled trial. BMC Musculoskelet Disord. 2023 Jul 17;24(1):580. doi: 10.1186/s12891-023-06693-3.

    PubMed 37461024

Questions about this trial

What is this clinical trial studying?

A study testing Resistance Training in people with Musculoskeletal Injury and Muscle Weakness, run by Defence Medical Rehabilitation Centre, UK at 6 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Peter Ladlow, PhD (+44 (0)1509251500 ext. 3403, peter.ladlow100@mod.gov.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Lower Extremity Functional Scale (LEFS) over time (time frame: Baseline, week 3 and week 15). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05719922, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in